About 200 reports

##. Gastrointestinal Drugs Market – Europe Analysis

  • Gastrointestinal Drug
  • Digestive System Disorder
  • In-Store Retail
  • Europe
  • Drug Approval
  • Biosimilar Approvals

##. Gastrointestinal Drugs Market – North America Analysis

  • Digestive System Disorder
  • Gastrointestinal Drug
  • In-Store Retail
  • North America
  • Drug Approval
  • Use Of Prescription Drugs

Figure ##. Gastrointestinal Drugs Market Segmentation

  • Gastrointestinal Drug
  • Digestive System Disorder
  • In-Store Retail
  • Middle East
  • Africa
  • Drug Approval
  • Health Expenditure

##.## US: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million) .....

  • Digestive System Disorder
  • Gastrointestinal Drug
  • In-Store Retail
  • World
  • APAC
  • Europe
  • North America
  • Middle East
  • Drug Approval
  • Health Expenditure

Figure ##. Gastrointestinal Drugs Market Segmentation

  • Gastrointestinal Drug
  • Digestive System Disorder
  • In-Store Retail
  • Central America
  • Drug Approval
  • Health Expenditure

Major companies in the gastrointestinal drugs market include Takeda Pharmaceticals; Allergan Plc; Novo Nordisk A/S; AstraZeneca Plc and Johnson & Johnson. The global gastrointestinal drugs market is expected to grow from $46.68 billion in 2020 to $48.74 billion in 2021 at a compound annual growth rate (CAGR) of 4.4%. The change in growth...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Health Expenditure
  • Population Over Age Of 65

World Digestive System Disorder Gastrointestinal Drug

  • Pharmaceutical
  • Gastrointestinal Drug
  • Digestive System Disorder
  • World
  • United States
  • Chongqing Municipality
  • Drug Approval
  • HIV AIDS Prevalence

Constipation (Gastrointestinal) - Drugs in Development, 2021 Summary Constipation (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Constipation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Constipation,...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • Research And Development
  • Drug Development
  • World

World Gastrointestinal Drug Therapy Digestive System Disorder

  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • China
  • South Korea
  • Pharmaceutical Registrations
  • Medical Technology Density

Infectious Diarrhea (Gastrointestinal) - Drugs in Development, 2021 Summary Infectious Diarrhea (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Infectious Diarrhea pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • Research And Development
  • World

Traveler’s Diarrhea (Gastrointestinal) - Drugs in Development, 2021 Summary Traveler’s Diarrhea (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Traveler’s Diarrhea pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • Research And Development
  • World

Gastrointestinal Drug

  • Gastrointestinal Drug
  • Europe
  • Pharmaceutical Exports
  • Number Of Enterprises

IBS-D RedHill Biopharma IBS- Inc. United States Indiana Hospital Discharge Digestive System Disorder Gastrointestinal Drug

  • Digestive System Disorder
  • Gastrointestinal Drug
  • European Union
  • Pharmaceutical Exports
  • Hospital Discharge

Abstract: - Global Oncology Nutrition Market to Reach $2.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Oncology Nutrition estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$2.5 Billion by 2027, growing at a CAGR of 7.3% over the analysis period 2020-2027....

  • Gastrointestinal Drug
  • World
  • China
  • United States

Abstract: - Global Portable Monitoring Devices Market to Reach $35.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Portable Monitoring Devices estimated at US$23.9 Billion in the year 2020, is projected to reach a revised size of US$35.5 Billion by 2027, growing at a CAGR of 5.8% over the analysis...

  • Neurology
  • Gastrointestinal Drug
  • World
  • China
  • United States

Table ##: Gastrointestinal Disorders, Global, Pipeline Programs Targeting Adiponectin, 2019

  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Smoking Prevalence
  • Drug Approval

Gastrointestinal Drug

  • Gastrointestinal Drug
  • United States
  • North America
  • Health Expenditure
  • Drug Approval

Gastrointestinal Drug

  • Gastrointestinal Drug
  • Central America
  • Overweight Prevalence
  • Health Expenditure

Gastrointestinal Drug

  • Gastrointestinal Drug
  • Middle East
  • Africa
  • Overweight Prevalence
  • Health Expenditure

KEY FINDINGS The global irritable bowel syndrome treatment market is predicted to grow with a CAGR of 7.25%, during the forecast period of 2021 to 2028. The market growth is mainly fueled by factors like, the rising prevalence of gastrointestinal ailments, the increasing number of FDA approvals and drug developments, the...

  • Gastrointestinal Drug
  • Digestive System Disorder
  • Drug Development
  • World
  • APAC
  • Drug Approval
  • Elderly Population

Gastrointestinal Drug Digestive System Disorder Diagnostics

  • Gastrointestinal Drug
  • Digestive System Disorder
  • Diagnostics
  • APAC
  • World
  • Europe
  • Diagnostic Revenue
  • Drug Approval

Gastrointestinal Drug

  • Gastrointestinal Drug
  • APAC
  • Overweight Prevalence
  • Health Expenditure

World East Asia Gastrointestinal Drug Pharmaceutical

  • Gastrointestinal Drug
  • World
  • China
  • South Korea
  • Pharmaceutical Registrations
  • Medical Technology Density

Gastrointestinal Drug Digestive System Disorder Diagnostics

  • Gastrointestinal Drug
  • Digestive System Disorder
  • Diagnostics
  • Central America
  • Drug Approval
  • Diagnostic Revenue

World Gastrointestinal Drug Digestive System Disorder

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • United States
  • Indiana
  • HIV AIDS Prevalence
  • Manufacturing Output

IBS- Inc. Gastrointestinal Drug Digestive System Disorder Diagnostics

  • Gastrointestinal Drug
  • Digestive System Disorder
  • Diagnostics
  • United States
  • North America
  • Canada
  • Drug Approval
  • Diagnostic Revenue

Synthetic Peptides to Antagonize CRHR## and CRHR## for Gastrointestinal Disorders – Drug Profile

  • Gastrointestinal Drug
  • Digestive System Disorder
  • World
  • United States
  • North America
  • Medical Technology Density
  • HIV AIDS Prevalence

Synthetic Peptides to Antagonize CRHR## and CRHR## for Gastrointestinal Disorders – Drug Profile

  • Gastrointestinal Drug
  • Digestive System Disorder
  • World
  • Ghana
  • Jiangsu
  • Indiana
  • Drug Approval
  • Medical Technology Density

Gastrointestinal Drug OTC

  • Gastrointestinal Drug
  • World
  • APAC
  • Overweight Prevalence
  • Health Expenditure

KEY FINDINGS The global bowel management system market is set to project a CAGR of 3.12% during the forecast period, 2021-2028. The increasing aging population, the growing incidence of gastrointestinal disorders, and the rising prevalence of irritable bowel syndrome, are driving the market growth. MARKET...

  • Gastrointestinal Drug
  • World
  • APAC